Further research is required to confirm ERCC1 expression detection as an appropriate predictor of CCRT treatment efficacy, and to test the possibility of combining ERCC1 inhibitors to improve CCRT efficacy for colorectal cancer patients. Here, ERCC1 is linked to colorectal cancer.